Key Finding
HIV patients with amphetamine-type stimulant exposure showed significantly impaired immune reconstitution after two years of antiretroviral therapy, with a hazard ratio of 0.558 for achieving adequate immune response compared to non-users.
A large Chinese study examined how amphetamine-type stimulants (ATS), such as methamphetamine, affect immune system recovery in people living with HIV who are taking antiretroviral therapy (ART). Researchers followed 2,372 patients for two years, comparing those with a history of ATS use to those without. They found that people with ATS exposure had significantly weaker immune responses even when taking their HIV medications consistently. Specifically, the ATS group showed slower recovery of CD4+ T-cells (the immune cells that HIV destroys), smaller increases in these protective cells, and delayed immune responses overall. The longer someone had used ATS, the worse their immune recovery tended to be. This research highlights an important health concern, as ATS use and HIV infection commonly occur together. The weakened immune response in ATS users means they may be more vulnerable to infections and AIDS-related complications despite proper medication adherence. For patients living with HIV who have used or currently use stimulants, this study emphasizes the importance of addressing substance use as part of comprehensive care. While this research doesn't directly involve acupuncture, many people living with HIV explore complementary therapies like acupuncture to support overall wellness, manage medication side effects, and address substance use issues. If you're considering acupuncture as part of your HIV care plan, it's essential to work with a licensed acupuncturist experienced in treating immune-compromised patients.
This retrospective cohort study from China's National Free Antiretroviral Treatment Program analyzed 2,372 propensity-matched HIV-positive patients (2016-2022) comparing those with and without amphetamine-type stimulant (ATS) exposure. All participants had low baseline CD4+ counts and high ART adherence. After two years, the ATS group demonstrated significantly impaired immune reconstitution with lower immune response rates, delayed time to response, reduced CD4+ T-cell count increases, and slower initial CD4+ growth rates. Cox regression identified ATS exposure as an independent risk factor for poor immune response (HR: 0.558, 95% CI: 0.485-0.643, P<0.001). Dose-response relationship was evident, with longer ATS exposure correlating with worse outcomes. Clinical takeaway: Practitioners treating HIV-positive patients with stimulant use history should anticipate compromised immune reconstitution despite medication adherence, warranting enhanced monitoring and integrated substance use interventions to optimize treatment outcomes.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.